Katherine M. Ruzhansky

Katherine M. Ruzhansky

Neurology
1600 Midtown Ave
1st Floor
Mount Pleasant, SC 29464

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Reply to the Letter to the Editor: The Role of Patient-Reported Symptoms in Standardizing MGFA Class 0 and MGFA-PIS.

Reply to the Letter to the Editor: The Role of Patient-Reported Symptoms in Standardizing MGFA Class 0 and MGFA-PIS.

Journal: Muscle & nerve
Published: August 26, 2025

Usability of the zilucoplan prefilled syringe for the treatment of generalized myasthenia gravis: insights from a human factors validation study.

Usability of the zilucoplan prefilled syringe for the treatment of generalized myasthenia gravis: insights from a human factors validation study.

Journal: Expert review of medical devices
Published: October 15, 2024

Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice: A Report of the MGFA Task Force.

Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice: A Report of the MGFA Task Force.

Journal: Muscle & nerve
Published: June 18, 2024

Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter Study.

Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter Study.

Journal: Pediatric neurology
Published: July 20, 2023

Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials.

Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials.

Journal: Neurology
Published: September 07, 2022

The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events.

The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events.

Journal: PloS one
Published: May 28, 2021

Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE).

Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE).

Journal: Muscle & nerve
Published: July 30, 2020

Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.

Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.

Journal: Muscle & nerve
Published: June 09, 2018

Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.

Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.

Journal: Neurology
Published: March 07, 2017

Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.

Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.

Journal: Muscle & nerve
Published: September 19, 2016

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.

Journal: Muscle & nerve
Published: December 15, 2015

Causes of neuropathy in patients referred as "idiopathic neuropathy".

Causes of neuropathy in patients referred as "idiopathic neuropathy".

Journal: Muscle & nerve
Published: July 15, 2015
Showing 1-12 of 15

Last Updated: 09/26/2026